{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:13:27Z","timestamp":1789035207230,"version":"build-2803163510"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020206","name":"Health Commission of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Ubiquitination is a crucial post-translational modification of proteins in eukaryotic cells. Deubiquitinating enzymes (DUBs) remove ubiquitin molecules from substrate proteins, thereby reversing ubiquitination and maintaining intracellular ubiquitin homeostasis. Dysregulation or dysfunction of DUBs is closely associated with various diseases. Among them, the ubiquitin-specific protease (USP) family, the largest subfamily of DUBs, plays a key regulatory role in tumor initiation and progression. This article systematically reviews the research progress on five representative USP family members closely linked to tumors, including USP7, USP22, USP10, USP35, and USP4, with a focus on their functional mechanisms in regulating major tumor-related signaling molecules and pathways, including p53, PTEN, c-Myc, and PD-L1. It also highlights their dual regulatory roles in tumor proliferation, resistance to apoptosis, metastasis, and immune evasion. Furthermore, this review summarizes the structural basis of USP catalysis and selectivity, the determinants of context-dependent USP functions, and the emerging roles of DUBs in tumor microenvironment remodeling and therapy resistance. We also discuss the latest advances in the development of selective inhibitors and new therapeutic modalities targeting these USPs, including PROTAC-mediated degradation, DUBTAC-mediated tumor suppressor stabilization, and molecular glue strategies. Although targeting DUBs for cancer therapy faces challenges such as substrate diversity, context-dependent functions, and functional redundancy within the family, it remains a promising strategy for tumor treatment. This review provides a theoretical foundation and research directions for further understanding the roles and mechanisms of the USP family in cancer and for developing targeted DUB-based anti-tumor therapies.<\/jats:p>","DOI":"10.3389\/fphar.2026.1933967","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:45:01Z","timestamp":1789033501000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory roles of five key USP family deubiquitinases in cancer: from mechanisms to targeted therapy advances"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1541-7786.MCR-22-0259","article-title":"Regulation of cyclin D1 degradation by ubiquitin-specific protease 27X is critical for cancer cell proliferation and tumor growth","volume":"20","author":"Alam","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/10799893.2025.2548246","article-title":"Targeting ubiquitin-specific peptidase 22 (USP22) as a nexus for drug repurposing in anticancer therapeutic development","volume":"45","author":"Alshehri","year":"2025","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2017.02.011","article-title":"USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth","volume":"131","author":"An","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.celrep.2019.02.054","article-title":"FOXM1 deubiquitination by USP21 regulates cell cycle progression and paclitaxel sensitivity in basal-like breast cancer","volume":"26","author":"Arceci","year":"2019","journal-title":"Cell Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/embor.2011.140","article-title":"USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1","volume":"12","author":"Atanassov","year":"2011","journal-title":"EMBO Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.molcel.2009.06.015","article-title":"Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance","volume":"35","author":"Atanassov","year":"2009","journal-title":"Mol. Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.molcel.2016.03.030","article-title":"ATXN7L3 and ENY2 coordinate activity of multiple H2B deubiquitinases important for cellular proliferation and tumor growth","volume":"62","author":"Atanassov","year":"2016","journal-title":"Mol. Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41418-020-00697-5","article-title":"Deubiquitylases in developmental ubiquitin signaling and congenital diseases","volume":"28","author":"Basar","year":"2021","journal-title":"Cell Death Differ."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-24-0293","article-title":"The USP1 inhibitor KSQ-4279 overcomes PARP inhibitor resistance in homologous recombination-deficient tumors","volume":"84","author":"Cadzow","year":"2024","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s42003-025-07513-1","article-title":"USP35 promotes the growth of ER positive breast cancer by inhibiting ferroptosis via BRD4-SLC7A11 axis","volume":"8","author":"Cao","year":"2025","journal-title":"Commun. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/14728222.2023.2266571","article-title":"Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment","volume":"27","author":"Carreira","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"B12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12967-023-04304-2","article-title":"USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1","volume":"21","author":"Chen","year":"","journal-title":"J. Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0290688","DOI":"10.1371\/journal.pone.0290688","article-title":"USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2","volume":"18","author":"Chen","year":"","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"149818","DOI":"10.1016\/j.bbrc.2024.149818","article-title":"USP7 interacts with and destabilizes oncoprotein SET","volume":"709","author":"Chen","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/jmv.70168","article-title":"USP7 inhibitors destabilize EBNA1 and suppress epstein-barr virus tumorigenesis","volume":"97","author":"Chen","year":"2025","journal-title":"J. Med. Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12502","DOI":"10.1021\/acs.jmedchem.6c00407","article-title":"Structure-guided discovery of OAT-4828 as potent, selective, and orally bioavailable USP7 inhibitor with in vivo antileukemic activity","volume":"69","author":"Chrzanowski","year":"2026","journal-title":"J. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","article-title":"USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","article-title":"The role of ubiquitination in tumorigenesis and targeted drug discovery","volume":"5","author":"Deng","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"145164","DOI":"10.1016\/j.ijbiomac.2025.145164","article-title":"The structural, functional, and regulatory insight of deubiquitinating enzyme - USP22","volume":"318","author":"Devi","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e70572","DOI":"10.1002\/cnr2.70572","article-title":"Decoding the oncogenic role of USP22 through pan-cancer genomic and epigenetic analysis","volume":"9","author":"Devi","year":"2026","journal-title":"Cancer Rep. Hob."},{"key":"B22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1172\/JCI73733","article-title":"The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer","volume":"124","author":"Diefenbacher","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10495-021-01706-9","article-title":"The deubiquitinase Usp27x as a novel regulator of cFLIPL protein expression and sensitizer to death-receptor-induced apoptosis","volume":"27","author":"Dold","year":"2022","journal-title":"Apoptosis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cell.2008.10.051","article-title":"FAM\/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination","volume":"136","author":"Dupont","year":"2009","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.tibs.2025.07.009","article-title":"E3 ubiquitin ligases in signaling, disease, and therapeutics","volume":"50","author":"Ebadi","year":"2025","journal-title":"Trends biochem. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molcel.2019.05.027","article-title":"TSPYL5 depletion induces specific death of ALT cells through USP7-dependent proteasomal degradation of POT1","volume":"75","author":"Episkopou","year":"2019","journal-title":"Mol. Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1083\/jcb.200807137","article-title":"USP7 counteracts SCF\u03b2TrCP- but not APCCdh1-mediated proteolysis of claspin","volume":"184","author":"Faustrup","year":"2009","journal-title":"J. Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13578-024-01291-9","article-title":"Deubiquitinase USP10 promotes osteosarcoma autophagy and progression through regulating GSK3\u03b2-ULK1 axis","volume":"14","author":"Feng","year":"2024","journal-title":"Cell Biosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"109693","DOI":"10.1016\/j.isci.2024.109693","article-title":"Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity","volume":"27","author":"Futran","year":"2024","journal-title":"iScience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e99692","DOI":"10.15252\/embj.201899692","article-title":"USP7 limits CDK1 activity throughout the cell cycle","volume":"40","author":"Galarreta","year":"2021","journal-title":"EMBO J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.3390\/ijms20236013","article-title":"Usp10 modulates the hippo pathway by deubiquitinating and stabilizing the transcriptional coactivator yorkie","volume":"20","author":"Gao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-023-02805-y","article-title":"Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application","volume":"42","author":"Gao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nchembio.2528","article-title":"Discovery and characterization of highly potent and selective allosteric USP7 inhibitors","volume":"14","author":"Gavory","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/ijc.32523","article-title":"A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis","volume":"146","author":"Geng","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.4161\/cc.5.11.2796","article-title":"Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated polycomb group (PcG) protein chromatin silencing pathway","volume":"5","author":"Glinsky","year":"2006","journal-title":"Cell Cycle"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1101\/gad.340133.120","article-title":"MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity","volume":"34","author":"Grunblatt","year":"2020","journal-title":"Genes Dev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"918314","DOI":"10.3389\/fimmu.2022.918314","article-title":"Immune evasion and drug resistance mediated by USP22 in cancer: novel targets and mechanisms","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41389-024-00524-3","article-title":"USP21-mediated G3BP1 stabilization accelerates proliferation and metastasis of esophageal squamous cell carcinoma via activating Wnt\/\u03b2-Catenin signaling","volume":"13","author":"Guo","year":"2024","journal-title":"Oncogenesis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12885-025-13964-w","article-title":"Oncogenic and immunological functions of USP35 in pan-cancer and its potential as a biomarker in kidney clear cell carcinoma","volume":"25","author":"Guo","year":"2025","journal-title":"BMC Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e18249","DOI":"10.1002\/anie.202518249","article-title":"Construction of small-molecule deubiquitinase-targeting chimeras to reactivate and stabilize mutant p53 Y220C in vitro and in vivo","volume":"65","author":"He","year":"2026","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","article-title":"Deubiquitinase-targeting chimeras for targeted protein stabilization","volume":"18","author":"Henning","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41594-021-00682-7","article-title":"Structure of the human SAGA coactivator complex","volume":"28","author":"Herbst","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12964-024-01633-7","article-title":"Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion","volume":"22","author":"Hsu","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"117522","DOI":"10.1016\/j.bcp.2025.117522","article-title":"USP7 inhibitor P5091 enhances the antitumor efficacy of vemurafenib in BRAFV600E-mutant thyroid cancer via ferroptosis","volume":"243","author":"Hu","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2326-6066.CIR-18-0910","article-title":"USP22 deubiquitinates CD274 to suppress anticancer immunity","volume":"7","author":"Huang","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"114917","DOI":"10.1016\/j.celrep.2024.114917","article-title":"USP7 deubiquitinates KRAS and promotes non-small cell lung cancer","volume":"43","author":"Huang","year":"2024","journal-title":"Cell Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1038\/s41467-019-12143-3","article-title":"USP7 inhibits Wnt\/\u03b2-catenin signaling through promoting stabilization of axin","volume":"10","author":"Ji","year":"2019","journal-title":"Nat. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"115732","DOI":"10.1016\/j.intimp.2025.115732","article-title":"Discovery of o-aminodiphenyl-based USP7 inhibitor for immune activation and antitumor response in colorectal cancer","volume":"167","author":"Jia","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41419-025-07736-4","article-title":"Mechanical signal modulates prostate cancer immune escape by USP8-mediated ubiquitination-dependent degradation of PD-L1 and MHC-1","volume":"16","author":"Ke","year":"2025","journal-title":"Cell Death Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e202302533","DOI":"10.26508\/lsa.202302533","article-title":"Variety in the USP deubiquitinase catalytic mechanism","volume":"7","author":"Keijzer","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1002\/jcp.25841","article-title":"Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells","volume":"232","author":"Kim","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.3390\/ijms27083404","article-title":"Fine-tuning protein fate: mechanisms of E1, E2, and E3 enzymes and deubiquitinases in cell signaling","volume":"27","author":"Kim","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1038\/s41467-026-72295-x","article-title":"Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors","volume":"17","author":"Klink","year":"2026","journal-title":"Nat. Commun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2010.04.026","article-title":"Structural basis for assembly and activation of the heterotetrameric SAGA histone H2B deubiquitinase module","volume":"141","author":"K\u00f6hler","year":"2010","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41418-019-0420-8","article-title":"USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity","volume":"27","author":"Kosinsky","year":"2020","journal-title":"Cell Death Differ."},{"key":"B60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41420-024-01894-8","article-title":"USP22 regulates APL differentiation via PML-RAR\u03b1 stabilization and IFN repression","volume":"10","author":"Kowald","year":"2024","journal-title":"Cell Death Discov."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41418-023-01219-9","article-title":"USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1","volume":"30","author":"Kuang","year":"2023","journal-title":"Cell Death Differ."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.chembiol.2017.09.003","article-title":"Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7","volume":"24","author":"Lamberto","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1158\/0008-5472.CAN-18-0753","article-title":"TGF\u03b2-activated USP27X deubiquitinase regulates cell migration and chemoresistance via stabilization of Snail1","volume":"79","author":"Lambies","year":"2019","journal-title":"Cancer Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: from mechanisms to their inhibition by small molecules","volume":"82","author":"Lange","year":"2022","journal-title":"Mol. Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41467-020-20259-0","article-title":"Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem\/progenitor cells in chronic myelogenous leukemia","volume":"12","author":"Lei","year":"2021","journal-title":"Nat. Commun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1242\/jcs.201855","article-title":"Mechanisms of regulation and diversification of deubiquitylating enzyme function","volume":"130","author":"Leznicki","year":"2017","journal-title":"J. Cell Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"jcs212753","DOI":"10.1242\/jcs.212753","article-title":"Expansion of DUB functionality generated by alternative isoforms \u2013 USP35, a case study","volume":"131","author":"Leznicki","year":"2018","journal-title":"J. Cell Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/ijms22030986","article-title":"Molecular mechanisms of DUBs regulation in signaling and disease","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/s1097-2765(04)00157-1","article-title":"A dynamic role of HAUSP in the p53-Mdm2 pathway","volume":"13","author":"Li","year":"2004","journal-title":"Mol. Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41419-018-0523-z","article-title":"The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/cancers12061582","article-title":"The deubiquitinase USP4 stabilizes Twist1 protein to promote lung cancer cell stemness","volume":"12","author":"Li","year":"","journal-title":"Cancers"},{"key":"B73","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2326-6066.CIR-19-0661","article-title":"Tumor cell-intrinsic USP22 suppresses antitumor immunity in pancreatic cancer","volume":"8","author":"Li","year":"","journal-title":"Cancer Immunol. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cac2.12460","article-title":"USP51\/PD-L1\/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer","volume":"43","author":"Li","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e2315541121","DOI":"10.1073\/pnas.2315541121","article-title":"USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy","volume":"121","author":"Li","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.scib.2024.04.017","article-title":"P53 upregulation by USP7-engaging molecular glues","volume":"69","author":"Li","year":"","journal-title":"Sci. Bull."},{"key":"B77","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12967-024-06001-0","article-title":"A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting \u03b2-catenin and Twist1 degradation","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"114765","DOI":"10.1016\/j.isci.2026.114765","article-title":"PCMTD1-127aa suppresses osteosarcoma progression by competitively binding to USP10 to promote c-MYC degradation","volume":"29","author":"Li","year":"","journal-title":"iScience"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1825797","DOI":"10.3389\/fonc.2026.1825797","article-title":"The deubiquitinase USP35: from an oncogenic hub to a therapeutic target in human cancers","volume":"16","author":"Li","year":"","journal-title":"Front. Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"C355","DOI":"10.1152\/ajpcell.00733.2024","article-title":"USP35 promotes breast cancer progression by regulating PFK-1 ubiquitination to mediate glycolysis","volume":"328","author":"Lian","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4251\/wjgo.v16.i3.1006","article-title":"Ubiquitin-specific protease 21 promotes tumorigenicity and stemness of colorectal cancer by deubiquitinating and stabilizing ZEB1","volume":"16","author":"Lin","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.celrep.2013.11.029","article-title":"USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation","volume":"5","author":"Lin","year":"2013","journal-title":"Cell Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41467-017-00206-2","article-title":"Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41374-021-00725-z","article-title":"Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer","volume":"102","author":"Liu","year":"","journal-title":"Lab. Invest."},{"key":"B85","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1021\/jacs.2c04824","article-title":"TF-DUBTACs stabilize tumor suppressor transcription factors","volume":"144","author":"Liu","year":"","journal-title":"J. Am. Chem. Soc."},{"key":"B86","doi-asserted-by":"publisher","first-page":"116974","DOI":"10.1016\/j.biopha.2024.116974","article-title":"The secoiridoid glycoside gentiopicroside is a USP22 inhibitor with potent antitumor immunotherapeutic activity","volume":"177","author":"Lu","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"116468","DOI":"10.1016\/j.ejmech.2024.116468","article-title":"Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression","volume":"272","author":"Lu","year":"","journal-title":"Eur. J. Med. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"108775","DOI":"10.1016\/j.bioorg.2025.108775","article-title":"Discovery of a ubiquitin-specific protease 10 inhibitor with high binding affinity promoting cell apoptosis via down-regulated CDK4 for the treatment of hepatocellular carcinoma","volume":"163","author":"Lu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7150\/ijbs.87176","article-title":"Ubiquitin-specific protease 35 promotes gastric cancer metastasis by increasing the stability of Snail1","volume":"20","author":"Ma","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/s41401-026-01826-5","article-title":"USP22 deubiquitinates and stabilizes ERK1\/2 to promote colorectal cancer progression","volume":"47","author":"Ma","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"B91","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1158\/0008-5472.CAN-19-1033","article-title":"USP22 functions as an oncogenic driver in prostate cancer by regulating cell proliferation and DNA repair","volume":"80","author":"McCann","year":"2020","journal-title":"Cancer Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","article-title":"DUBs, hypoxia, and cancer","volume":"5","author":"Mennerich","year":"2019","journal-title":"Trends Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"eabo4116","DOI":"10.1126\/sciadv.abo4116","article-title":"A deubiquitination module essential for Treg fitness in the tumor microenvironment","volume":"8","author":"Montauti","year":"2022","journal-title":"Sci. Adv."},{"key":"B94","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1126\/science.aac5681","article-title":"Structural basis for histone H2B deubiquitination by the SAGA DUB module","volume":"351","author":"Morgan","year":"2016","journal-title":"Science"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/s41388-021-01679-8","article-title":"The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer","volume":"40","author":"Morgan","year":"2021","journal-title":"Oncogene"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/s41418-023-01228-8","article-title":"USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A","volume":"30","author":"Mu","year":"2023","journal-title":"Cell Death Differ."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e012287","DOI":"10.1136\/jitc-2025-012287","article-title":"Therapeutic inhibition of USP7 promotes antitumor immune responses","volume":"13","author":"Muchowicz","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"S4210","DOI":"10.4103\/jpbs.jpbs_517_24","article-title":"Deubiquitinases and cancer","volume":"16","author":"Murali","year":"2024","journal-title":"J. Pharm. Bioallied Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","article-title":"The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway","volume":"17","author":"Nijman","year":"2005","journal-title":"Mol. Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.apsb.2025.03.004","article-title":"USP51\/GRP78\/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells","volume":"15","author":"Ou","year":"2025","journal-title":"Acta. Pharm. Sin. B"},{"key":"B101","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s13238-019-00674-w","article-title":"USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer","volume":"11","author":"Pan","year":"2020","journal-title":"Protein Cell"},{"key":"B166","doi-asserted-by":"publisher","first-page":"18984","DOI":"10.1038\/s41598-026-49053-6","article-title":"USP7-dependent stabilization of FKBP4 contributes to acquired osimertinib resistance through glycolytic remodeling in NSCLC","volume":"16","author":"Pang","year":"2026","journal-title":"Sci. Rep."},{"key":"B102","doi-asserted-by":"publisher","first-page":"188992","DOI":"10.1016\/j.bbcan.2023.188992","article-title":"Current and future directions of USP7 interactome in cancer study","volume":"1878","author":"Park","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41467-018-03107-0","article-title":"USP35 regulates mitotic progression by modulating the stability of Aurora B","volume":"9","author":"Park","year":"2018","journal-title":"Nat. Commun."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e202204395","DOI":"10.1002\/anie.202204395","article-title":"Discovery of a potent and selective degrader for USP7","volume":"61","author":"Pei","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B105","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5483\/BMBRep.2019.52.3.048","article-title":"Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?","volume":"52","author":"Poondla","year":"2019","journal-title":"BMB Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ncb1601","article-title":"The ubiquitin-specific protease USP28 is required for MYC stability","volume":"9","author":"Popov","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.chembiol.2017.09.004","article-title":"USP7-specific inhibitors target and modify the enzyme's active site via distinct chemical mechanisms","volume":"24","author":"Pozhidaeva","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1038\/s41388-024-03141-x","article-title":"USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer","volume":"43","author":"Reissland","year":"2024","journal-title":"Oncogene"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e2303807","DOI":"10.1002\/advs.202303807","article-title":"Deubiquitylating enzymes in cancer and immunity","volume":"10","author":"Ren","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s10637-020-00915-4","article-title":"Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and\/or refractory multiple myeloma","volume":"38","author":"Rowinsky","year":"2020","journal-title":"Invest. New Drugs"},{"key":"B112","doi-asserted-by":"publisher","first-page":"188903","DOI":"10.1016\/j.bbcan.2023.188903","article-title":"USP7 \u2013 a crucial regulator of cancer hallmarks","volume":"1878","author":"Saha","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1126\/science.1190049","article-title":"Structural insights into the assembly and function of the SAGA deubiquitinating module","volume":"328","author":"Samara","year":"2010","journal-title":"Science"},{"key":"B114","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1158\/0008-5472.CAN-13-1954","article-title":"USP22 regulates oncogenic signaling pathways to drive lethal cancer progression","volume":"74","author":"Schrecengost","year":"2014","journal-title":"Cancer Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1128\/MCB.00373-15","article-title":"Deubiquitinase USP47\/UBP64E regulates \u03b2-Catenin ubiquitination and degradation and plays a positive role in Wnt signaling","volume":"35","author":"Shi","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s42003-023-05345-5","article-title":"Structural and functional characterization of USP47 reveals a hot spot for inhibitor design","volume":"6","author":"Shin","year":"2023","journal-title":"Commun. Biol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"B044","DOI":"10.1158\/2326-6074.IO2026-B044","article-title":"Abstract B044: USP27X plays a crucial role in controlling the cancer cell growth and shaping the tumor immune microenvironment","volume":"14","author":"Singh","year":"2026","journal-title":"Cancer Immunol. Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response","volume":"297","author":"Snyder","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nature07290","article-title":"The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network","volume":"455","author":"Song","year":"2008","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.1021\/acs.jmedchem.5c00102","article-title":"Ubiquitin-specific protease 7 (USP7) as a promising therapeutic target for drug discovery: from mechanisms to therapies","volume":"68","author":"Song","year":"2025","journal-title":"J. Med. Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.jid.2025.03.021","article-title":"Selective USP7 inhibition synergizes with MEK1\/2 inhibitor to enhance immune responses and potentiate anti-PD-1 therapy in NRAS-mutant melanoma","volume":"145","author":"Su","year":"2025","journal-title":"J. Invest. Dermatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41467-019-08334-7","article-title":"Usp7 regulates hippo pathway through deubiquitinating the transcriptional coactivator yorkie","volume":"10","author":"Sun","year":"2019","journal-title":"Nat. Commun."},{"key":"B124","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1002\/ctm2.390","article-title":"Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin","volume":"11","author":"Tang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"107672","DOI":"10.1016\/j.jbc.2024.107672","article-title":"USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion","volume":"300","author":"Tang","year":"2024","journal-title":"J. Biol. Chem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10238-025-01878-7","article-title":"Research progress of DUB enzyme in breast cancer","volume":"25","author":"Tang","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/genes13050831","article-title":"USP10 as a potential therapeutic target in human cancers","volume":"13","author":"Tao","year":"2022","journal-title":"Genes"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nm.4180","article-title":"HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma","volume":"22","author":"Tavana","year":"2016","journal-title":"Nat. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"108865","DOI":"10.1016\/j.pharmthera.2025.108865","article-title":"USP1 inhibition: a journey from target discovery to clinical translation","volume":"271","author":"Torrado","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41418-025-01494-8","article-title":"Lactylation-driven USP4-mediated ANXA2 stabilization and activation promotes maintenance and radioresistance of glioblastoma stem cells","volume":"32","author":"Tu","year":"2025","journal-title":"Cell Death Differ."},{"key":"B132","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"key":"B133","doi-asserted-by":"publisher","first-page":"30962","DOI":"10.18632\/oncotarget.8821","article-title":"USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment","volume":"7","author":"Vogel","year":"2016","journal-title":"Oncotarget"},{"key":"B134","doi-asserted-by":"publisher","first-page":"26979","DOI":"10.1038\/srep26979","article-title":"The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"B135","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12964-020-00612-y","article-title":"The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells","volume":"18","author":"Wang","year":"","journal-title":"Cell Commun. Signal"},{"key":"B136","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12935-020-01391-9","article-title":"USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target","volume":"20","author":"Wang","year":"","journal-title":"Cancer Cell Int."},{"key":"B137","doi-asserted-by":"publisher","first-page":"13754","DOI":"10.1021\/jacs.5c01889","article-title":"USP28-based deubiquitinase-targeting chimeras for cancer treatment","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"B138","doi-asserted-by":"publisher","first-page":"109348","DOI":"10.1016\/j.bioorg.2026.109348","article-title":"Discovery of a novel USP10 inhibitor with improved aqueous solubility for the treatment of hepatocellular carcinoma","volume":"169","author":"Wang","year":"2026","journal-title":"Bioorg. Chem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15252\/embr.201541392","article-title":"The deubiquitinase Usp27x stabilizes the BH3-only protein bim and enhances apoptosis","volume":"17","author":"Weber","year":"2016","journal-title":"EMBO Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"13644","DOI":"10.1038\/ncomms13644","article-title":"K63-polyubiquitinated HAUSP deubiquitinates HIF-1\u03b1 and dictates H3K56 acetylation promoting hypoxia-induced tumour progression","volume":"7","author":"Wu","year":"2016","journal-title":"Nat. Commun."},{"key":"B141","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41389-023-00458-2","article-title":"USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer","volume":"12","author":"Xiao","year":"2023","journal-title":"Oncogenesis"},{"key":"B142","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1186\/s12967-025-06812-9","article-title":"USP5-mediated PD-L1 deubiquitination regulates immunotherapy efficacy in melanoma","volume":"23","author":"Xie","year":"2025","journal-title":"J. Transl. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-023-06304-yx","article-title":"Phosphorylation of USP27X by GSK3\u03b2 maintains the stability and oncogenic functions of CBX2","volume":"14","author":"Xing","year":"2023","journal-title":"Cell Death Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s41467-022-29401-6","article-title":"USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy","volume":"13","author":"Xiong","year":"2022","journal-title":"Nat. Commun."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e3002446","DOI":"10.1371\/journal.pbio.3002446","article-title":"FBXO3 stabilizes USP4 and Twist1 to promote PI3K-mediated breast cancer metastasis","volume":"21","author":"Xu","year":"2023","journal-title":"PLoS Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41419-025-08322-4","article-title":"De-ubiquitinase USP35 promotes peritoneal dissemination of gastric cancer by regulating metabolic reprogramming","volume":"16","author":"Yan","year":"","journal-title":"Cell Death Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40246-025-00850-6","article-title":"Comprehensive pan-cancer analysis of USP35 and validation of its role in gastric cancer","volume":"19","author":"Yan","year":"","journal-title":"Hum. Genomics"},{"key":"B148","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-025-02392-8","article-title":"Targeting ubiquitination in disease and therapy","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"B149","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","article-title":"The increasing complexity of the ubiquitin code","volume":"18","author":"Yau","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-025-02502-8","article-title":"Immune-related deubiquitylation spectrum of microsatellite stability colorectal cancer reveals USP7 as a potential immunotherapeutic target","volume":"25","author":"Yin","year":"2025","journal-title":"Mol. Cancer"},{"key":"B151","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41401-020-0455-x","article-title":"Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways","volume":"42","author":"Yu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"B152","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","article-title":"USP10 regulates p53 localization and stability by deubiquitinating p53","volume":"140","author":"Yuan","year":"2010","journal-title":"Cell"},{"key":"B153","doi-asserted-by":"publisher","first-page":"28595","DOI":"10.1074\/jbc.M114.596056","article-title":"The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7","volume":"289","author":"Zemp","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B154","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","article-title":"The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression","volume":"29","author":"Zhang","year":"2008","journal-title":"Mol. Cell"},{"key":"B155","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb2522","article-title":"USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-\u03b2 type I receptor","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/ncb2874","article-title":"Deubiquitylation and stabilization of PTEN by USP13","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41392-020-0118-x","article-title":"CDK4\/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B158","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41418-020-0588-y","article-title":"Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer","volume":"28","author":"Zhang","year":"2021","journal-title":"Cell Death Differ."},{"key":"B159","doi-asserted-by":"publisher","first-page":"106842","DOI":"10.1016\/j.bioorg.2023.106842","article-title":"Discovery of selective and potent USP22 inhibitors via structure-based virtual screening and bioassays exerting anti-tumor activity","volume":"141","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1016\/j.apsb.2024.08.004","article-title":"Demethylzeylasteral induces PD-L1 ubiquitin-proteasome degradation and promotes antitumor immunity via targeting USP22","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"B161","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00018-025-05826-2","article-title":"USP4-mediated deubiquitination of A2AR suppresses autophagy-dependent ferroptosis in gastric cancer","volume":"82","author":"Zhao","year":"2025","journal-title":"Cell Mol. Life Sci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1573406413666171020115539","article-title":"USP7: target validation and drug discovery for cancer therapy","volume":"14","author":"Zhou","year":"2018","journal-title":"Med. Chem."},{"key":"B163","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41419-025-08052-7","article-title":"The multifaceted roles of deubiquitinating enzymes (DUBs) in pancreatic ductal adenocarcinoma","volume":"16","author":"Zhou","year":"2025","journal-title":"Cell Death Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"118865","DOI":"10.1016\/j.ejmech.2026.118865","article-title":"USP22 in human cancers: mechanistic insights and inhibitor development","volume":"312","author":"Zhou","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-19-2388","article-title":"USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP\/TAZ","volume":"80","author":"Zhu","year":"2020","journal-title":"Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1933967\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:45:03Z","timestamp":1789033503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1933967\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":166,"alternative-id":["10.3389\/fphar.2026.1933967"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1933967","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1933967"}}